I Brain RoboticsBook a demo
Blog

Alma TED FDA Approval: A Comprehensive Comparison with InFuze™ for Advanced Non-Surgical Hair Restoration

I Brain Robotics Team · 2026-01-04

Hair loss affects millions of men and women worldwide and continues to be one of the most emotionally impactful aesthetic and medical concerns. While surgical hair transplantation remains a gold standard for advanced hair loss, the demand for non-surgical hair restoration solutions has surged dramatically in recent years. Patients today seek treatments that are effective, comfortable, needle-free, and require little to no downtime. Physicians, on the other hand, look for technologies that are safe, versatile, evidence-based, and financially sustainable for their practices.


One of the most discussed non-surgical hair restoration technologies in recent years is Alma TED, often searched online under terms like Alma TED FDA approval. At the same time, a new generation of advanced permeation systems—most notably InFuze™ by i-Brain Robotics—is redefining what non-invasive hair restoration can truly achieve.


ALMA TED FDA APPROVAL: A COMPREHENSIVE COMPARISON WITH INFUZE™ FOR ADVANCED NON-SURGICAL HAIR RESTORATION
Alma TED FDA Approval

Understanding Alma TED FDA Approval: What It Really Means

FDA Approval vs. FDA Clearance

A common misconception among patients and even some providers is the idea that Alma TED is “FDA approved” for hair regrowth. In reality, Alma TED is FDA-cleared, not FDA-approved.

The U.S. Food and Drug Administration (FDA) distinguishes between:

Alma TED received FDA 510(k) clearance as an acoustic wave–based device intended for use on the scalp. This clearance confirms that the device is safe to use within its intended parameters, but it does not imply FDA endorsement of hair regrowth claims.

This distinction is crucial when evaluating non-surgical hair restoration technologies and comparing them to more advanced delivery platforms like InFuze™.


What Is Alma TED?

Alma TED (TransEpidermal Delivery) is a non-invasive hair treatment device developed by Alma Lasers. It uses acoustic sound waves to enhance scalp permeability and assist in the topical delivery of hair-supporting compounds.

Core Technology Behind Alma TED

Alma TED is positioned as a comfortable alternative to injection-based therapies such as PRP or mesotherapy.


Limitations of Alma TED in Clinical Practice

While Alma TED FDA clearance establishes safety, several limitations become evident when the technology is evaluated more deeply from a physician’s and patient’s perspective:

1. Limited Depth Control

Acoustic energy primarily affects the superficial scalp layers. There is limited precision in targeting follicular structures, where hair regeneration processes occur.

2. Restricted Compatibility

Alma TED typically relies on pre-defined topical formulations, limiting a physician’s ability to customize treatment protocols.

3. Less Control Over Dosage

Without controlled high-velocity delivery or sealed contact, product distribution may vary from patient to patient.

4. Narrow Scope of Use

Alma TED is primarily marketed for scalp hair and does not offer the same versatility across facial or skin rejuvenation indications.


Understanding Non-Surgical Hair Restoration

Non-surgical hair restoration refers to treatments that aim to reduce hair loss, improve scalp health, and stimulate hair growth without hair transplant surgery. These treatments typically focus on:

Modern non-surgical solutions increasingly rely on energy-assisted transdermal delivery systems rather than simple topical products or painful injections.


Introducing InFuze™: The Next Evolution in Non-Surgical Hair Restoration

InFuze™ by i-Brain Robotics represents a more advanced, physician-driven approach to non-surgical hair restoration. Unlike surface-focused acoustic devices, InFuze™ combines focused ultrasonic permeation with pulsed high-velocity transdermal delivery, enabling deeper, more uniform, and more controlled delivery of therapeutic actives—without needles.


InFuze™ Technology Overview

Dual-Action Delivery System

InFuze™ employs a proprietary combination of:

1. Ultrasonic Permeation (40 kHz)

2. Pulsed High-Velocity TDA (Up to 450 m/s)

This dual-technology architecture places InFuze™ in a higher technological category than acoustic-only devices like Alma TED.


Key Features of InFuze™


Alma TED vs. InFuze™: Side-by-Side Comparison

Technology Depth

Precision & Control

Formulation Freedom

Patient Experience

Practice ROI


Why InFuze™ Is the Better Choice for Patients

1. Completely Painless Experience

InFuze™ treatments are needle-free and atraumatic. Patients typically feel only mild warmth or gentle vibration, making the procedure ideal for individuals with needle anxiety or low pain tolerance.

2. Zero Downtime

Patients can return to work, exercise, and daily activities immediately after treatment. There is no redness, bruising, or recovery period.

3. Better Results Through Precision

By delivering bioactive compounds directly toward follicular structures, InFuze™ maximizes the effectiveness of each session, often leading to visible improvements in hair quality and density over a structured treatment plan.

4. Suitable for All Hair Loss Types

InFuze™ is effective for:

5. Long-Term Hair Health

Rather than offering only cosmetic improvement, InFuze™ supports follicular health, scalp circulation, and sustained hair vitality.


Why InFuze™ Is the Better Choice for Physicians

1. Clinical Flexibility

Physicians can customize treatment protocols using:

This flexibility allows providers to tailor treatments based on patient diagnosis and progression.

2. Expanded Patient Base

Because InFuze™ is painless and non-invasive, clinics can treat:

3. Efficient Workflow

This efficiency improves clinic throughput and profitability.

4. Strong Safety Profile

5. Higher Patient Satisfaction and Retention

Comfortable treatments with visible results lead to:


How InFuze™ Hair Restoration Works

Step 1: Scalp Assessment

The clinician evaluates scalp condition, hair density, and hair loss pattern to determine the appropriate protocol.

Step 2: Selection of Active Compounds

Physician-selected solutions are prepared based on patient needs.

Step 3: Ultrasonic Permeation

Low-frequency ultrasound temporarily enhances scalp permeability.

Step 4: Pulsed High-Velocity Delivery

Micro-droplets are propelled toward the dermis and follicular structures with precision.

Step 5: Uniform Coverage

The sealed-contact applicator ensures consistent dosing across the scalp.

Step 6: Post-Treatment

No downtime is required. Patients resume normal activities immediately.


Treatment Protocol and Expected Results

Results vary based on individual biology, hair loss severity, and formulation used.


Address and Contact Information

i-Brain Robotics Inc. United States

Orlando Office:7380 West Sand Lake Rd, Dr Phillips Orlando, FL 32819, USA

Melbourne Office:310 N Wickham Rd, Unit #129Melbourne, FL 32935, USA

Email:info@ibrainrobotics.net

Phone: (352) 804-6054

Website:www.ibrainrobotics.net


Conclusion

While searches for Alma TED FDA approval reflect growing interest in non-surgical hair restoration, FDA clearance alone does not define clinical effectiveness or long-term value. Alma TED offers a safe, comfortable introduction to acoustic-based scalp treatments, but its limitations in depth, precision, and versatility are clear.

InFuze™ stands apart as a more advanced, physician-driven platform, combining ultrasonic permeation with pulsed high-velocity delivery to achieve deeper, more uniform, and more customizable results—without needles or downtime. For both patients seeking meaningful outcomes and physicians building future-ready practices, InFuze™ represents the superior evolution of non-surgical hair restoration technology.